Aquagenic pruritus in essential thrombocythemia is associated with a higher risk of thrombosis-Reference-Cited by-同舟云学术

Aquagenic pruritus in essential thrombocythemia is associated with a higher risk of thrombosis

Published:2019-09-08 Issue:11 Volume:17 Page:1950-1955
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Le Gall‐Ianotto Christelle¹²^ORCID,Le Calloch Ronan³,Couturier Marie‐Anne⁴,Chauveau Aurélie⁵⁶,Lippert Eric⁵⁶,Carré Jean‐Luc²⁷,Misery Laurent¹²,Ianotto Jean‐Christophe⁴⁶

Affiliation:

1. Department of Dermatology University Hospital of Brest Brest France

2. Laboratory of Interactions Neurons‐Keratinocytes University of Brest Brest France

3. Department of Internal Medicine‐Hematology Hospital of Cornouaille Quimper France

4. Department of Clinical Hematology University Hospital of Brest Brest France

5. Laboratory of Hematology University Hospital of Brest Brest France

6. France Intergroup of Myeloproliferative Neoplasms (FIM) France

7. Laboratory of Biochemistry University Hospital of Brest Brest France

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14588

Reference17 articles.

1. Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

2. Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

3. Clinical characteristics of aquagenic pruritus in patients with myeloproliferative neoplasms

4. Pruritus in polycythemia vera is associated with a lower risk of arterial thrombosis

5. Masked polycythemia Vera (mPV): Results of an international study

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The burden of symptoms and quality of life of filipino patients with myeloproliferative neoplasm: A multicenter cross‐sectional survey;Asia-Pacific Journal of Clinical Oncology;2024-07-17

2. Differences between aquagenic and non‐aquagenic pruritus in myeloproliferative neoplasms: An observational study of 500 patients;Journal of the European Academy of Dermatology and Venereology;2023-03-09

3. Essential thrombocytosis: diagnosis, differential diagnosis, complications and treatment considerations of relevance for a cardiologist;Netherlands Heart Journal;2023-02-09

4. Rationale and design of the multicentric, double-blind, double-placebo, randomized trial APrepitant versus HYdroxyzine in association with cytoreductive treatments for patients with myeloproliferative neoplasia suffering from Persistent Aquagenic Pruritus. Trial acronym: APHYPAP;Trials;2021-12

5. Low-Risk Essential Thrombocythemia: A Comprehensive Review;HemaSphere;2021-01-27